Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.36 trillion and total revenue of $123.43 billion.
Market Cap
1.36T
Revenue
123.43B
Profits
-32.66B
PE Ratio
n/a
Profit Margin
-26.46%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.69B | -0.16% | 1,024,245 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 100.63B | -0.85% | 7,552,628 | 2.53B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 96.27B | 4.73% | 1,217,003 | 16.90B |
| 4 | ARGX | argenx SE | 61.12B | 0.62% | 245,634 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.97B | -0.95% | 486,039 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 40.16B | 0.81% | 3,532,642 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 39.08B | -6.40% | 3,256,571 | 197.56M |
| 8 | GMAB | Genmab A/S | 33.33B | -0.37% | 3,863,420 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 30.32B | 1.60% | 7,913,107 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.49B | 1.05% | 1,488,393 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.92B | 1.64% | 1,187,340 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.73B | 0.50% | 764,869 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.41B | 5.41% | 3,328,826 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.25B | 0.17% | 1,361,653 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 17.03B | 1.05% | 881,896 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.93B | 1.14% | 592,827 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.49B | 1.11% | 2,324,722 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 13.31B | -6.67% | 3,822,249 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.59B | -1.26% | 2,504,458 | 1.80B |
| 20 | KYMR | Kymera Therapeutics, Inc. | 11.51B | -1.32% | 551,602 | 102.24M |
| 21 | TECH | Bio-Techne Corporation | 11.44B | -0.03% | 2,599,863 | 1.23B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.30B | 2.10% | 1,654,708 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.86B | 3.41% | 1,640,564 | - |
| 24 | SYRE | Spyre Therapeutics, Inc. | 10.14B | 2.24% | 1,036,346 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.06B | 0.10% | 296,515 | 1.43B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.68B | 2.55% | 717,339 | 7.46M |
| 27 | MTRI | Mentari Therapeutics, Inc. | 9.38B | 27.94% | 59,654 | - |
| 28 | TGTX | TG Therapeutics, Inc. | 9.21B | 2.33% | 2,053,208 | 897.76M |
| 29 | KRYS | Krystal Biotech, Inc. | 9.15B | 0.75% | 174,761 | 470.03M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.80B | -1.03% | 332,589 | 551.69M |
| 31 | ABVX | ABIVAX Société Anonyme | 8.19B | 1.60% | 738,764 | 5.33M |
| 32 | CORT | Corcept Therapeutics Incorporated | 8.16B | 1.61% | 1,115,676 | 963.65M |
| 33 | CYTK | Cytokinetics, Incorporated | 8.15B | 4.18% | 2,810,649 | 113.29M |
| 34 | AXSM | Axsome Therapeutics, Inc. | 7.85B | 5.87% | 1,067,246 | 865.27M |
| 35 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.78B | -1.57% | 734,103 | 280.75M |
| 36 | TWST | Twist Bioscience Corporation | 7.69B | -7.22% | 3,357,901 | 431.80M |
| 37 | IMVT | Immunovant, Inc. | 7.67B | 3.72% | 1,712,162 | - |
| 38 | ORKA | Oruka Therapeutics, Inc. | 7.27B | -2.13% | 843,874 | - |
| 39 | IBRX | ImmunityBio, Inc. | 7.10B | -1.11% | 11,925,039 | 182.57M |
| 40 | CAI | Caris Life Sciences, Inc. | 7.02B | 0.25% | 4,681,720 | 1.05B |
| 41 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.97B | 0.73% | 2,528,651 | 669.50M |
| 42 | KOD | Kodiak Sciences Inc. | 6.86B | 1.18% | 688,278 | - |
| 43 | MANE | Veradermics, Incorporated | 6.61B | 5.47% | 648,759 | - |
| 44 | CGON | CG Oncology, Inc. | 6.49B | -0.04% | 890,126 | 6.17M |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.34B | 0.85% | 121,693 | 253.83M |
| 46 | BLTE | Belite Bio, Inc | 6.28B | -0.37% | 260,022 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.18B | 0.20% | 528,387 | 670.78M |
| 48 | ERAS | Erasca, Inc. | 5.88B | 8.53% | 13,790,190 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 5.69B | -2.92% | 1,487,938 | 570.00K |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.42B | 1.20% | 541,079 | 1.16B |
| 51 | EWTX | Edgewise Therapeutics, Inc. | 5.21B | 2.24% | 1,343,118 | - |
| 52 | COGT | Cogent Biosciences, Inc. | 5.12B | -7.08% | 4,512,277 | - |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 5.03B | 0.55% | 733,883 | 2.72M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.00B | 0.10% | 750,777 | 651.03M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.72B | -0.49% | 1,441,299 | - |
| 56 | IONS | Ionis Pharmaceuticals, Inc. | 4.72B | 0.50% | 5,477,134 | 960.09M |
| 57 | CRSP | CRISPR Therapeutics AG | 4.44B | 1.33% | 2,671,671 | 25.17M |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.36B | 5.88% | 3,860,874 | 53.81M |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.36B | -1.10% | 1,932,007 | 10.35M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 4.14B | 1.72% | 1,252,261 | 7.50M |
| 61 | IRON | Disc Medicine, Inc. | 3.97B | 2.88% | 669,013 | - |
| 62 | ABCL | AbCellera Biologics Inc. | 3.87B | -4.09% | 2,851,103 | 67.85M |
| 63 | LEGN | Legend Biotech Corporation | 3.79B | -4.26% | 4,413,405 | 1.36B |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.78B | 3.97% | 726,635 | 682.20M |
| 65 | ELVN | Enliven Therapeutics, Inc. | 3.77B | -0.02% | 781,455 | - |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | 0.12% | 8,398,944 | 378.98M |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.66B | -1.23% | 546,012 | 148.00K |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.63B | -0.77% | 2,644,191 | - |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.59B | 3.63% | 2,456,696 | 508.68M |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.55B | 1.26% | 2,826,411 | 26.31M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.37B | 0.39% | 1,909,757 | - |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.36B | 2.91% | 273,996 | 890.79M |
| 73 | ACAD | Acadia Pharmaceuticals Inc. | 3.17B | 0.49% | 2,392,418 | 1.20B |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.16B | 3.04% | 793,842 | 36.54M |
| 75 | DNLI | Denali Therapeutics Inc. | 3.16B | -0.60% | 873,556 | 21.38M |
| 76 | CELC | Celcuity Inc. | 3.16B | -4.07% | 694,376 | - |
| 77 | VCEL | Vericel Corporation | 3.03B | 0.71% | 808,229 | 324.17M |
| 78 | XNCR | Xencor, Inc. | 3.00B | 1.47% | 1,103,234 | 200.49M |
| 79 | ZLAB | Zai Lab Limited | 2.97B | -0.04% | 919,811 | 441.73M |
| 80 | ADMA | ADMA Biologics, Inc. | 2.93B | 4.10% | 2,556,630 | 519.15M |
| 81 | MBX | MBX Biosciences, Inc. | 2.87B | 2.47% | 556,534 | - |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.71B | 0.70% | 914,960 | 100.00M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.57B | 2.62% | 1,582,465 | 146.64M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.48B | 8.03% | 2,622,392 | 25.94M |
| 85 | PHVS | Pharvaris N.V. | 2.40B | 0.56% | 421,682 | - |
| 86 | PVLA | Palvella Therapeutics, Inc. | 2.40B | -2.83% | 241,508 | - |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -1.63% | 589,048 | 158.00K |
| 88 | SEPN | Septerna, Inc. | 2.31B | -7.22% | 1,127,402 | 96.27M |
| 89 | BHVN | Biohaven Ltd. | 2.29B | 0.53% | 1,596,578 | - |
| 90 | IMNM | Immunome, Inc. | 2.25B | 2.25% | 872,891 | 4.02M |
| 91 | VIR | Vir Biotechnology, Inc. | 2.25B | -0.15% | 1,288,027 | 302.80M |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.24B | 1.13% | 15,148,327 | 68.23M |
| 93 | VERA | Vera Therapeutics, Inc. | 2.20B | 1.50% | 1,709,145 | 10.28M |
| 94 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -0.55% | 1,591,112 | 321.74M |
| 95 | TRAX | First Tracks Biotherapeutics, Inc. | 2.12B | -3.44% | 487,072 | - |
| 96 | LKFT | Lakefront Biotherapeutics NV | 2.12B | -0.21% | 195,092 | 1.13B |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.11B | -0.64% | 1,517,265 | - |
| 98 | REPL | Replimune Group, Inc. | 2.06B | -6.44% | 3,028,236 | - |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | 2.00% | 971,350 | 989.36M |
| 100 | MAZE | Maze Therapeutics, Inc. | 2.01B | 3.61% | 484,131 | 20.00M |
| 101 | ZYME | Zymeworks Inc. | 2.01B | -7.60% | 897,858 | 265.97M |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | -2.04% | 2,036,294 | 213.00M |
| 103 | FTRE | Fortrea Holdings Inc. | 1.97B | -4.72% | 1,518,181 | 2.67B |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | 3.34% | 844,598 | 140.84M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.95B | 0.42% | 305,638 | 11.00M |
| 106 | KLRA | Kailera Therapeutics, Inc. | 1.87B | 0.98% | 609,998 | - |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | 1.44% | 655,780 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.82B | 2.02% | 834,933 | 28.21M |
| 109 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 0.45% | 329,514 | 4.44M |
| 110 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 1.58% | 1,996,348 | 1.96B |
| 111 | NRIX | Nurix Therapeutics, Inc. | 1.78B | 2.83% | 2,513,605 | 701.94M |
| 112 | MESO | Mesoblast Limited | 1.76B | -2.43% | 138,806 | 120.25M |
| 113 | ABSI | Absci Corporation | 1.74B | 1.50% | 4,893,924 | 1.56M |
| 114 | GENB | Generate Biomedicines, Inc. | 1.73B | -2.10% | 454,774 | 26.48M |
| 115 | QURE | uniQure N.V. | 1.72B | 8.26% | 2,464,863 | 20.17M |
| 116 | BRVE | Braveheart Bio, Inc. | 1.71B | 6.52% | 488,966 | - |
| 117 | SLS | SELLAS Life Sciences Group, Inc. | 1.70B | 0.60% | 3,774,568 | - |
| 118 | RARE | Ultragenyx Pharmaceutical Inc. | 1.70B | 3.47% | 2,673,622 | 730.00M |
| 119 | PGEN | Precigen, Inc. | 1.69B | 4.42% | 4,609,402 | 156.94M |
| 120 | NVAX | Novavax, Inc. | 1.65B | -2.16% | 5,889,479 | 411.65M |
| 121 | NBTX | Nanobiotix S.A. | 1.64B | 0.24% | 63,895 | 13.15M |
| 122 | IMCR | Immunocore Holdings plc | 1.64B | -2.25% | 368,135 | 429.30M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.60B | 4.08% | 626,291 | 20.00M |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 2.15% | 3,030,367 | 52.89M |
| 125 | NUVB | Nuvation Bio Inc. | 1.51B | 2.14% | 2,951,500 | 201.73M |
| 126 | GPCR | Structure Therapeutics Inc. | 1.49B | -3.59% | 1,001,659 | - |
| 127 | ADRX | ADARx Pharmaceuticals, Inc. | 1.49B | -1.99% | 509,927 | 6.13M |
| 128 | KARD | Kardigan, Inc. | 1.47B | 3.29% | 432,159 | - |
| 129 | OCUL | Ocular Therapeutix, Inc. | 1.47B | 0.76% | 2,988,272 | 50.38M |
| 130 | ANAB | AnaptysBio, Inc. | 1.46B | 0.81% | 230,346 | 106.09M |
| 131 | KRSA | Korsana Biosciences, Inc. | 1.45B | 2.35% | 167,277 | - |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.45B | -0.14% | 532,134 | - |
| 133 | LBRX | LB Pharmaceuticals Inc | 1.45B | -0.51% | 341,759 | - |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.44B | -3.73% | 535,808 | - |
| 135 | MLYS | Mineralys Therapeutics, Inc. | 1.43B | 4.12% | 1,885,661 | - |
| 136 | AVLN | Avalyn Pharma Inc. | 1.40B | 1.44% | 474,404 | - |
| 137 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | 0.12% | 1,736,588 | 5.49M |
| 138 | MNKD | MannKind Corporation | 1.35B | -0.95% | 3,282,469 | 413.37M |
| 139 | SVRA | Savara Inc. | 1.34B | 1.42% | 9,253,946 | - |
| 140 | INVA | Innoviva, Inc. | 1.34B | -1.15% | 649,315 | 438.32M |
| 141 | INBX | Inhibrx Biosciences, Inc. | 1.33B | -0.02% | 165,624 | 1.30M |
| 142 | AAPG | Ascentage Pharma Group International | 1.32B | -3.23% | 7,312 | 94.61M |
| 143 | GHRS | GH Research PLC | 1.32B | -1.58% | 127,770 | - |
| 144 | OMER | Omeros Corporation | 1.31B | 4.91% | 756,170 | 38.42M |
| 145 | NKTR | Nektar Therapeutics | 1.31B | 1.75% | 518,051 | 54.59M |
| 146 | DRTS | Alpha Tau Medical Ltd. | 1.29B | 2.34% | 833,495 | - |
| 147 | URGN | UroGen Pharma Ltd. | 1.28B | 3.08% | 811,277 | 250.25M |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.25B | 8.88% | 1,221,822 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.23B | 2.71% | 407,305 | - |
| 150 | SLN | Silence Therapeutics plc | 1.23B | -0.10% | 294,496 | 615.00K |
| 151 | SGP | SpyGlass Pharma, Inc. | 1.17B | 2.31% | 77,564 | - |
| 152 | MLTX | MoonLake Immunotherapeutics | 1.15B | 7.56% | 1,760,318 | - |
| 153 | VSTM | Verastem, Inc. | 1.15B | 4.12% | 2,552,679 | 100.30M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.14B | -3.00% | 225,685 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 1.05B | 0.85% | 678,937 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | 4.95% | 245,072 | 99.00K |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 967.53M | 0.88% | 822,118 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 947.76M | -2.35% | 173,880 | 10.06M |
| 159 | PHAR | Pharming Group N.V. | 943.24M | 1.36% | 12,712 | 386.75M |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 932.87M | 1.01% | 773,258 | - |
| 161 | IVA | Inventiva S.A. | 932.81M | 1.52% | 2,371,494 | 2.81M |
| 162 | MGTX | MeiraGTx Holdings plc | 929.70M | 0.62% | 455,889 | 397.50M |
| 163 | IMTX | Immatics N.V. | 914.46M | 4.21% | 964,082 | 49.33M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 896.37M | 1.43% | 198,821 | - |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 880.99M | -1.81% | 1,254,522 | 70.33M |
| 166 | BBTX | Bambusa Therapeutics, Inc. | 874.17M | 0.65% | 157,171 | - |
| 167 | SNDX | Syndax Pharmaceuticals, Inc. | 863.37M | 1.05% | 4,355,550 | 289.68M |
| 168 | ALMS | Alumis Inc. | 856.86M | 3.44% | 1,282,888 | 7.40M |
| 169 | SLDB | Solid Biosciences Inc. | 848.24M | 6.00% | 1,957,866 | - |
| 170 | CTY | City Therapeutics, Inc. | 846.36M | -13.30% | 458,676 | 14.34M |
| 171 | RIGL | Rigel Pharmaceuticals, Inc. | 838.31M | 1.39% | 140,655 | 288.21M |
| 172 | LXRX | Lexicon Pharmaceuticals, Inc. | 832.59M | 0.54% | 3,086,226 | 38.54M |
| 173 | SGMT | Sagimet Biosciences Inc. | 809.07M | 4.78% | 1,790,074 | - |
| 174 | ANNX | Annexon, Inc. | 799.30M | -0.48% | 3,075,164 | - |
| 175 | OBX | Obsidian Therapeutics, Inc. | 795.63M | -6.26% | 663,322 | - |
| 176 | AURA | Aura Biosciences, Inc. | 792.01M | -0.52% | 648,447 | - |
| 177 | ARDX | Ardelyx, Inc. | 786.80M | 3.99% | 3,292,454 | 468.22M |
| 178 | DBVT | DBV Technologies S.A. | 767.85M | 3.21% | 373,312 | 3.74M |
| 179 | PRME | Prime Medicine, Inc. | 764.99M | 10.26% | 12,842,710 | 4.07M |
| 180 | ATTO | Attovia Therapeutics, Inc. | 763.75M | 0.54% | 150,110 | 1.44M |
| 181 | JANX | Janux Therapeutics, Inc. | 758.06M | 2.91% | 1,189,478 | 23.29M |
| 182 | OABI | OmniAb, Inc. | 743.89M | - | 789,284 | 40.21M |
| 183 | CGEM | Cullinan Therapeutics, Inc. | 736.85M | 1.07% | 844,699 | - |
| 184 | IAM | Iambic Therapeutics, Inc. | 729.26M | 4.09% | 355,490 | 18.25M |
| 185 | NVCT | Nuvectis Pharma, Inc. | 722.17M | -0.38% | 153,122 | - |
| 186 | CLYM | Climb Bio, Inc. | 719.54M | 4.34% | 1,663,763 | - |
| 187 | IMMX | Immix Biopharma, Inc. | 717.94M | 3.71% | 1,057,095 | - |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 717.62M | 4.25% | 837,169 | 92.01M |
| 189 | KURA | Kura Oncology, Inc. | 710.22M | 2.11% | 3,651,503 | 79.31M |
| 190 | CADL | Candel Therapeutics, Inc. | 705.50M | -1.39% | 1,095,878 | - |
| 191 | ZVRA | Zevra Therapeutics, Inc. | 705.13M | -0.59% | 742,236 | 147.76M |
| 192 | OLMA | Olema Pharmaceuticals, Inc. | 704.35M | 10.59% | 1,819,379 | - |
| 193 | BCAX | Bicara Therapeutics Inc. | 699.06M | 3.44% | 1,506,014 | - |
| 194 | ANL | Adlai Nortye Group Ltd. | 698.72M | 8.94% | 195,930 | 18.06M |
| 195 | APMD | Apnimed, Inc. | 698.56M | 5.80% | 194,688 | 115.12M |
| 196 | AVBP | ArriVent BioPharma, Inc. | 698.52M | 0.11% | 910,925 | 5.00M |
| 197 | DSGN | Design Therapeutics, Inc. | 689.67M | 1.13% | 455,701 | - |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 688.38M | 4.58% | 1,980,953 | 6.40M |
| 199 | SANA | Sana Biotechnology, Inc. | 686.16M | -5.76% | 2,431,527 | - |
| 200 | HELP | Helus Pharma Inc. | 686.04M | 3.53% | 1,362,533 | - |
| 201 | WVE | Wave Life Sciences, Inc. | 674.52M | 0.29% | 1,702,429 | 70.92M |
| 202 | DNA | Ginkgo Bioworks Holdings, Inc. | 664.38M | -14.65% | 2,769,948 | 130.75M |
| 203 | GERN | Geron Corporation | 657.12M | 4.70% | 6,552,375 | 217.52M |
| 204 | CAPR | Capricor Therapeutics, Inc. | 652.35M | 26.49% | 9,962,775 | 11.13M |
| 205 | CBIO | Crescent Biopharma, Inc. | 631.53M | 6.00% | 269,517 | 11.88M |
| 206 | SRZN | Surrozen, Inc. | 607.69M | -2.33% | 156,970 | 10.53M |
| 207 | ABUS | Arbutus Biopharma Corporation | 594.78M | 1.57% | 2,129,447 | 181.49M |
| 208 | ETRA | Electra Therapeutics, Inc. | 593.15M | 18.27% | 384,954 | - |
| 209 | VALN | Valneva SE | 569.90M | 0.85% | 49,985 | 163.30M |
| 210 | RGNX | REGENXBIO Inc. | 560.06M | 10.14% | 1,845,043 | 153.91M |
| 211 | ENTX | Entera Bio Ltd. | 560.03M | -0.62% | 103,319 | 42.00K |
| 212 | EPRX | Eupraxia Pharmaceuticals Inc. | 529.88M | 5.64% | 615,646 | - |
| 213 | OVID | Ovid Therapeutics Inc. | 524.67M | -0.71% | 1,823,059 | 1.45M |
| 214 | DMAC | DiaMedica Therapeutics Inc. | 520.92M | -0.10% | 139,358 | - |
| 215 | NGNE | Neurogene Inc. | 519.59M | -0.71% | 199,761 | 925.00K |
| 216 | STTK | Shattuck Labs, Inc. | 514.30M | 4.12% | 983,939 | 1.00M |
| 217 | BLSM | BlossomHill Therapeutics, Inc. | 512.37M | 13.20% | 203,671 | - |
| 218 | PHAT | Phathom Pharmaceuticals, Inc. | 498.82M | 15.34% | 1,569,608 | 274.88M |
| 219 | INDP | Indaptus Therapeutics, Inc. | 493.00M | 10.69% | 264,680 | - |
| 220 | AVTX | Avalo Therapeutics, Inc. | 492.07M | 18.85% | 1,838,644 | 59.00K |
| 221 | MDXG | MiMedx Group, Inc. | 484.47M | -1.48% | 1,225,252 | 303.73M |
| 222 | MNPR | Monopar Therapeutics Inc. | 481.46M | -0.07% | 157,109 | - |
| 223 | OBIO | Orchestra BioMed Holdings, Inc. | 473.02M | 4.89% | 452,902 | 31.21M |
| 224 | RLMD | Relmada Therapeutics, Inc. | 472.55M | 3.75% | 1,346,324 | - |
| 225 | OCS | Oculis Holding AG | 469.78M | 0.26% | 227,358 | 1.12M |
| 226 | GYRE | Gyre Therapeutics, Inc. | 466.26M | 0.71% | 108,929 | 110.06M |
| 227 | CTMX | CytomX Therapeutics, Inc. | 464.35M | 7.58% | 4,991,409 | 14.03M |
| 228 | ASMB | Assembly Biosciences, Inc. | 455.47M | 4.78% | 203,140 | 74.85M |
| 229 | ARVN | Arvinas, Inc. | 452.50M | -0.14% | 730,098 | 275.30M |
| 230 | PRTA | Prothena Corporation plc | 448.28M | 1.99% | 392,227 | 52.74M |
| 231 | YDES | YD Bio Limited | 435.61M | 1.99% | 13,249 | 1.24M |
| 232 | TECX | Tectonic Therapeutic, Inc. | 429.30M | -0.05% | 133,273 | - |
| 233 | RZLT | Rezolute, Inc. | 426.96M | 1.24% | 974,182 | - |
| 234 | CTNM | Contineum Therapeutics, Inc. | 422.89M | 1.99% | 287,645 | - |
| 235 | PBYI | Puma Biotechnology, Inc. | 417.72M | -0.74% | 397,807 | 231.83M |
| 236 | IRD | Opus Genetics, Inc. | 416.58M | 1.89% | 1,206,811 | 7.91M |
| 237 | MPLT | MapLight Therapeutics, Inc. | 415.71M | 0.54% | 291,886 | - |
| 238 | LYEL | Lyell Immunopharma, Inc. | 414.51M | 0.66% | 153,668 | 15.00K |
| 239 | CRMD | CorMedix Inc. | 413.10M | -1.30% | 1,617,461 | 462.25M |
| 240 | SLBT | SL Science Holding Limited | 411.96M | -19.64% | 318,882 | 3.27M |
| 241 | ASPE | Aspen Neuroscience, Inc. | 401.87M | 7.88% | 290,415 | - |
| 242 | SPRY | ARS Pharmaceuticals, Inc. | 397.09M | 10.64% | 3,844,381 | 122.14M |
| 243 | ALEC | Alector, Inc. | 391.55M | 3.95% | 3,466,642 | 173.47M |
| 244 | PRLD | Prelude Therapeutics Incorporated | 389.32M | 0.53% | 295,281 | 22.42M |
| 245 | TRXB | TRex Bio, Inc. | 383.64M | 8.53% | 107,852 | - |
| 246 | CCCC | C4 Therapeutics, Inc. | 379.51M | -3.67% | 1,966,237 | 32.28M |
| 247 | ALT | Altimmune, Inc. | 375.42M | -0.52% | 2,688,827 | 31.00K |
| 248 | FENC | Fennec Pharmaceuticals Inc. | 373.11M | 0.57% | 268,794 | 59.22M |
| 249 | EDIT | Editas Medicine, Inc. | 367.33M | -4.99% | 1,968,781 | 49.83M |
| 250 | PEPG | PepGen Inc. | 364.31M | 14.10% | 15,898,312 | - |
| 251 | EIKN | Eikon Therapeutics, Inc. | 361.28M | 8.81% | 439,191 | - |
| 252 | DTIL | Precision BioSciences, Inc. | 349.26M | -3.68% | 250,718 | 45.04M |
| 253 | FTH | Faeth Therapeutics, Inc. | 344.97M | 3.33% | 1,362,494 | - |
| 254 | AGMB | AgomAb Therapeutics NV | 344.24M | - | 433,254 | - |
| 255 | PROK | ProKidney Corp. | 341.62M | 1.80% | 595,516 | 818.00K |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 338.88M | 0.48% | 320,528 | - |
| 257 | ENTA | Enanta Pharmaceuticals, Inc. | 337.85M | 3.39% | 208,853 | 65.26M |
| 258 | GALT | Galectin Therapeutics Inc. | 331.80M | -2.66% | 77,977 | - |
| 259 | BNTC | Benitec Biopharma Inc. | 330.34M | 2.05% | 120,637 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 329.83M | -0.46% | 775,638 | 16.96M |
| 261 | AUTL | Autolus Therapeutics plc | 328.71M | -6.44% | 3,839,135 | 137.43M |
| 262 | IKT | Inhibikase Therapeutics, Inc. | 327.37M | 5.16% | 413,405 | 1.00 |
| 263 | AGEN | Agenus Inc. | 326.68M | 2.85% | 429,708 | 133.95M |
| 264 | OCGN | Ocugen, Inc. | 325.87M | 1.09% | 4,491,845 | 4.78M |
| 265 | SCTX | Scribe Therapeutics Inc. | 319.19M | -2.88% | 367,555 | 33.30M |
| 266 | KYTX | Kyverna Therapeutics, Inc. | 316.64M | 0.79% | 504,108 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 315.07M | 3.57% | 327,716 | 109.16M |
| 268 | TTRX | Turn Therapeutics Inc. | 314.86M | 6.55% | 56,535 | - |
| 269 | EVMN | Evommune, Inc. | 312.84M | 9.95% | 1,432,904 | 10.00M |
| 270 | CABA | Cabaletta Bio, Inc. | 312.79M | - | 3,763,560 | - |
| 271 | ALLO | Allogene Therapeutics, Inc. | 311.86M | -3.41% | 15,336,316 | 4.64M |
| 272 | VCRE | Vicore Pharma Holding AB (publ) | 311.26M | -0.35% | 9,763 | 383.48K |
| 273 | VOGX | Vogenx, Inc. | 308.54M | 7.84% | 127,908 | - |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 308.24M | 4.31% | 3,706,141 | 424.00K |
| 275 | FULC | Fulcrum Therapeutics, Inc. | 285.35M | 0.54% | 881,425 | 80.00M |
| 276 | LRMR | Larimar Therapeutics, Inc. | 284.97M | 1.49% | 977,333 | - |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 280.73M | 6.73% | 1,596,839 | 13.08M |
| 278 | SABS | SAB Biotherapeutics, Inc. | 280.18M | 1.30% | 774,162 | 114.70K |
| 279 | QTTB | Q32 Bio Inc. | 275.30M | -1.39% | 232,893 | 53.74M |
| 280 | RCKT | Rocket Pharmaceuticals, Inc. | 272.24M | 1.22% | 962,708 | - |
| 281 | ARCT | Arcturus Therapeutics Holdings Inc. | 268.34M | -0.85% | 443,207 | 30.51M |
| 282 | VTVT | vTv Therapeutics Inc. | 266.76M | 2.24% | 11,627 | 36.84M |
| 283 | INO | Inovio Pharmaceuticals, Inc. | 264.97M | 1.72% | 10,768,296 | 298.90K |
| 284 | PLX | Protalix BioTherapeutics, Inc. | 263.92M | 9.44% | 3,090,221 | 84.69M |
| 285 | CAMP | Camp4 Therapeutics Corporation | 263.57M | -3.00% | 95,222 | 5.32M |
| 286 | BCYC | Bicycle Therapeutics plc | 258.65M | - | 171,798 | 83.53M |
| 287 | CUVL | Clinuvel Pharmaceuticals Limited | 255.87M | -1.93% | 11,011 | 65.05M |
| 288 | LXEO | Lexeo Therapeutics, Inc. | 251.87M | 0.33% | 527,423 | - |
| 289 | VNDA | Vanda Pharmaceuticals Inc. | 250.95M | 1.72% | 687,927 | 229.28M |
| 290 | IMRX | Immuneering Corporation | 245.45M | -1.56% | 455,725 | - |
| 291 | GLSI | Greenwich LifeSciences, Inc. | 236.17M | 0.12% | 118,459 | - |
| 292 | ACIU | AC Immune SA | 224.70M | -1.31% | 91,386 | 23.75M |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 217.18M | -3.26% | 530,324 | - |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 209.86M | -0.15% | 124,210 | 1.03M |
| 295 | PALI | Palisade Bio, Inc. | 209.76M | 3.54% | 2,836,126 | 500.00K |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 207.57M | 3.09% | 14,167 | 1.80M |
| 297 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 205.25M | 16.36% | 1,423,486 | - |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 201.19M | 0.25% | 870,833 | 251.00K |
| 299 | TRDA | Entrada Therapeutics, Inc. | 198.60M | 3.62% | 691,004 | 3.98M |
| 300 | CGEN | Compugen Ltd. | 197.97M | - | 210,904 | 75.93M |
| 301 | KRRO | Korro Bio, Inc. | 197.79M | -8.39% | 192,691 | 1.29M |
| 302 | MDWD | MediWound Ltd. | 197.49M | -2.06% | 147,255 | 11.86M |
| 303 | PYXS | Pyxis Oncology, Inc. | 195.91M | 0.61% | 665,204 | 11.04M |
| 304 | FATE | Fate Therapeutics, Inc. | 192.31M | -9.32% | 2,646,063 | 4.75M |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 191.19M | 5.19% | 452,794 | 7.15M |
| 306 | ACOG | Alpha Cognition Inc. | 187.73M | -1.26% | 124,959 | 15.26M |
| 307 | KROS | Keros Therapeutics, Inc. | 187.22M | 2.25% | 174,549 | 40.76M |
| 308 | ZNTL | Zentalis Pharmaceuticals, Inc. | 185.72M | 5.00% | 1,354,001 | 26.87M |
| 309 | DRUG | Bright Minds Biosciences Inc. | 178.28M | 3.72% | 160,761 | - |
| 310 | VRXA | Veraxa Biotech AG | 178.17M | 17.76% | 269,973 | 29.54K |
| 311 | PRQR | ProQR Therapeutics N.V. | 177.81M | -3.82% | 352,675 | 21.05M |
| 312 | IVVD | Invivyd, Inc. | 176.65M | 4.33% | 1,719,174 | 58.37M |
| 313 | UPB | Upstream Bio, Inc. | 175.40M | -5.33% | 1,317,547 | 2.87M |
| 314 | IFRX | InflaRx N.V. | 173.89M | -2.48% | 577,422 | -38.53K |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 171.80M | 4.03% | 105,443 | 2.00M |
| 316 | STRO | Sutro Biopharma, Inc. | 170.12M | 0.88% | 138,824 | 45.70M |
| 317 | ANTX | AN2 Therapeutics, Inc. | 169.23M | 3.00% | 197,630 | - |
| 318 | YARW | Yarrow Bioscience, Inc. | 167.94M | 16.60% | 187,147 | - |
| 319 | SION | Sionna Therapeutics, Inc. | 167.37M | - | 646,940 | - |
| 320 | HUMA | Humacyte, Inc. | 164.37M | 0.29% | 6,701,093 | 2.40M |
| 321 | TARA | Protara Therapeutics, Inc. | 161.31M | 7.82% | 717,778 | - |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 155.38M | 4.84% | 625,585 | 1.50M |
| 323 | ALXO | ALX Oncology Holdings Inc. | 154.87M | 0.90% | 343,758 | - |
| 324 | CMPX | Compass Therapeutics, Inc. | 149.51M | -0.93% | 1,520,666 | 850.00K |
| 325 | IPHA | Innate Pharma S.A. | 148.78M | 3.25% | 7,572 | 11.21M |
| 326 | MGNX | MacroGenics, Inc. | 147.78M | -4.13% | 450,770 | 175.14M |
| 327 | NGEN | NervGen Pharma Corp. | 145.16M | 1.50% | 233,857 | - |
| 328 | ARMP | Armata Pharmaceuticals, Inc. | 144.64M | 3.73% | 50,548 | 5.54M |
| 329 | MSLE | Satellos Bioscience Inc. | 144.33M | -2.88% | 20,967 | - |
| 330 | ADAG | Adagene Inc. | 143.02M | 3.90% | 221,907 | 9.29M |
| 331 | ZURA | Zura Bio Limited | 137.75M | 1.78% | 6,589,344 | - |
| 332 | RNA | Atrium Therapeutics, Inc. | 136.16M | -3.28% | 130,118 | 35.84M |
| 333 | OKUR | OnKure Therapeutics, Inc. | 136.09M | -0.74% | 205,829 | - |
| 334 | CUE | Cue Biopharma, Inc. | 135.55M | -0.53% | 122,973 | 37.66M |
| 335 | PYPD | PolyPid Ltd. | 134.06M | 4.60% | 424,497 | - |
| 336 | SPRB | Spruce Biosciences, Inc. | 132.78M | -1.00% | 50,234 | 697.00K |
| 337 | ABEO | Abeona Therapeutics Inc. | 131.44M | -6.31% | 6,409,731 | 39.01M |
| 338 | MENS | Jyong Biotech Ltd. | 129.17M | -2.79% | 13,525 | - |
| 339 | LENZ | LENZ Therapeutics, Inc. | 129.14M | 0.24% | 604,873 | 12.36M |
| 340 | NERV | Minerva Neurosciences, Inc. | 127.58M | 2.81% | 95,694 | - |
| 341 | FHTX | Foghorn Therapeutics Inc. | 125.32M | 10.00% | 761,429 | 112.13M |
| 342 | ENGN | enGene Therapeutics Inc. | 120.63M | 7.78% | 2,484,326 | - |
| 343 | OTLK | Outlook Therapeutics, Inc. | 117.10M | 4.43% | 2,323,778 | -1.16M |
| 344 | MOLN | Molecular Partners AG | 115.56M | - | 460 | 856.30K |
| 345 | NTHI | NeOnc Technologies Holdings, Inc. | 112.35M | 3.43% | 306,333 | 39.99K |
| 346 | EQ | Equillium, Inc. | 111.28M | -2.41% | 212,197 | 4.39M |
| 347 | IMUX | Immunic, Inc. | 110.79M | 1.00% | 156,855 | - |
| 348 | VYGR | Voyager Therapeutics, Inc. | 109.52M | -3.56% | 623,458 | 25.11M |
| 349 | CLLS | Cellectis S.A. | 108.97M | 24.32% | 382,062 | 63.82M |
| 350 | CDXS | Codexis, Inc. | 106.92M | -2.36% | 1,667,435 | 77.68M |
| 351 | NKTX | Nkarta, Inc. | 106.12M | 9.63% | 1,098,642 | - |
| 352 | NRXP | NRx Pharmaceuticals, Inc. | 105.56M | 3.39% | 956,349 | 3.39M |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 105.29M | 3.28% | 630,711 | - |
| 354 | VANI | Vivani Medical, Inc. | 101.93M | -1.74% | 132,393 | - |
| 355 | KZIA | Kazia Therapeutics Limited | 101.82M | 0.41% | 154,472 | 1.27M |
| 356 | RTSN | Retension Pharmaceuticals, Inc. | 101.23M | 1.08% | 91,490 | - |
| 357 | NBP | NovaBridge Biosciences | 99.88M | 0.10% | 397,362 | - |
| 358 | AVXL | Anavex Life Sciences Corp. | 98.26M | -6.19% | 828,028 | - |
| 359 | PLYX | Polaryx Therapeutics, Inc. | 97.20M | 4.28% | 6,824 | - |
| 360 | HURA | TuHURA Biosciences, Inc. | 96.86M | 0.66% | 490,312 | - |
| 361 | ANIX | Anixa Biosciences, Inc. | 96.64M | -9.15% | 277,415 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 95.15M | 3.28% | 154,069 | - |
| 363 | TVGN | Tevogen Inc. | 94.42M | 4.90% | 3,080 | - |
| 364 | MIST | Milestone Pharmaceuticals Inc. | 93.31M | - | 6,450,417 | 2.34M |
| 365 | ICCC | ImmuCell Corporation | 92.55M | -0.68% | 3,364 | 30.68M |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 92.52M | 0.94% | 852,140 | 70.00M |
| 367 | TENX | Tenax Therapeutics, Inc. | 90.60M | - | 756,032 | - |
| 368 | CHRS | Coherus Oncology, Inc. | 90.02M | -9.11% | 5,357,115 | 53.64M |
| 369 | NMRA | Neumora Therapeutics, Inc. | 88.87M | 1.37% | 490,305 | - |
| 370 | CBUS | Cibus, Inc. | 88.66M | 1.31% | 83,076 | 4.35M |
| 371 | SEER | Seer, Inc. | 88.04M | -1.24% | 260,802 | 14.08M |
| 372 | RLYB | Rallybio Corporation | 85.07M | 0.25% | 44,473 | 434.00K |
| 373 | GNLX | Genelux Corporation | 84.25M | -3.59% | 292,378 | 8.00K |
| 374 | TNYA | Tenaya Therapeutics, Inc. | 83.23M | 0.16% | 1,015,570 | 3.03M |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 82.61M | 1.60% | 10,318 | 3.97M |
| 376 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 82.43M | 1.78% | 567,804 | - |
| 377 | TLSA | Tiziana Life Sciences Ltd | 79.51M | 1.77% | 359,529 | - |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 79.18M | 1.41% | 332,635 | 6.58M |
| 379 | NRXS | NeurAxis, Inc. | 75.72M | -3.52% | 202,889 | 6.53M |
| 380 | COYA | Coya Therapeutics, Inc. | 75.30M | 1.58% | 87,163 | 4.69M |
| 381 | TNXP | Tonix Pharmaceuticals Holding Corp. | 75.20M | -5.61% | 3,165,516 | 43.05M |
| 382 | OKYO | OKYO Pharma Limited | 74.52M | 2.90% | 59,877 | - |
| 383 | PDSB | PDS Biotechnology Corporation | 73.92M | -0.97% | 2,822,232 | - |
| 384 | NTRB | Nutriband Inc. | 72.20M | 3.13% | 7,579 | 1.62M |
| 385 | GOSS | Gossamer Bio, Inc. | 71.50M | 3.63% | 335,654 | 78.42M |
| 386 | CNXU | Conexeu Sciences Inc. | 69.68M | 1.80% | 240,156 | - |
| 387 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 18,848 | 920.48K |
| 388 | HRTX | Heron Therapeutics, Inc. | 68.37M | -3.96% | 4,711,705 | 148.22M |
| 389 | CING | Cingulate Inc. | 67.47M | 1.75% | 126,411 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 67.28M | - | 218,151 | - |
| 391 | VRCA | Verrica Pharmaceuticals Inc. | 67.17M | 11.08% | 62,285 | 30.32M |
| 392 | FBIO | Fortress Biotech, Inc. | 67.04M | 5.24% | 382,111 | 68.47M |
| 393 | CSBR | Champions Oncology, Inc. | 66.53M | 0.63% | 9,351 | 60.66M |
| 394 | CGTX | Cognition Therapeutics, Inc. | 64.41M | 1.06% | 200,006 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 62.65M | -1.90% | 218,624 | - |
| 396 | CLNN | Clene Inc. | 59.63M | -4.88% | 208,437 | 238.00K |
| 397 | CRDF | Cardiff Oncology, Inc. | 59.54M | -3.71% | 333,991 | 508.00K |
| 398 | XBIT | XBiotech Inc. | 59.45M | -1.02% | 18,546 | - |
| 399 | SPRO | Spero Therapeutics, Inc. | 59.40M | 0.99% | 149,774 | 47.00M |
| 400 | NORD | Nordicus Partners Corporation | 58.32M | 1.39% | 3,028 | - |
| 401 | BOLD | Boundless Bio, Inc. | 55.96M | 0.41% | 10,826 | - |
| 402 | XLO | Xilio Therapeutics, Inc. | 55.73M | -0.70% | 3,528 | 55.01M |
| 403 | RNXT | RenovoRx, Inc. | 55.06M | 3.39% | 256,004 | 2.78M |
| 404 | IBIO | iBio, Inc. | 53.00M | 5.67% | 358,650 | 100.00K |
| 405 | ANVS | Annovis Bio, Inc. | 52.92M | -2.40% | 1,605,730 | - |
| 406 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.51M | 0.85% | 23,850 | - |
| 407 | ONCY | Oncolytics Biotech Inc. | 52.48M | 7.81% | 1,157,691 | - |
| 408 | RNTX | Rein Therapeutics Inc. | 52.28M | 2.71% | 307,122 | - |
| 409 | INKT | MiNK Therapeutics, Inc. | 52.17M | 2.14% | 14,811 | - |
| 410 | AZR | Azora Therapeutics, Inc. | 49.99M | -6.65% | 11,027 | - |
| 411 | ATNM | Actinium Pharmaceuticals, Inc. | 49.99M | 1.27% | 115,520 | 35.09M |
| 412 | MREO | Mereo BioPharma Group plc | 48.96M | 2.92% | 386,687 | 800.00K |
| 413 | HYFT | MindWalk Holdings Corp. | 48.53M | - | 79,945 | 11.57M |
| 414 | GANX | Gain Therapeutics, Inc. | 48.44M | 2.78% | 291,864 | - |
| 415 | PLRX | Pliant Therapeutics, Inc. | 48.15M | -1.03% | 270,142 | - |
| 416 | HOWL | Werewolf Therapeutics, Inc. | 48.06M | 1.95% | 137,812 | 21.00M |
| 417 | ELTX | Elicio Therapeutics, Inc. | 46.14M | 1.24% | 357,038 | - |
| 418 | KLRS | Kalaris Therapeutics, Inc. | 45.23M | 1.60% | 66,623 | - |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 45.11M | -4.07% | 75,290 | 100.00K |
| 420 | BMEA | Biomea Fusion, Inc. | 44.28M | 11.68% | 692,452 | - |
| 421 | TELO | Telomir Pharmaceuticals, Inc. | 43.80M | 4.00% | 321,445 | - |
| 422 | CNTB | Connect Biopharma Holdings Limited | 43.38M | 0.98% | 288,220 | 2.95M |
| 423 | ATHE | Alterity Therapeutics Limited | 42.99M | -0.43% | 19,283 | 2.50M |
| 424 | TIL | Instil Bio, Inc. | 42.79M | -0.63% | 53,338 | - |
| 425 | IMA | ImageneBio, Inc. | 42.23M | -2.36% | 3,935 | 800.00K |
| 426 | CRBU | Caribou Biosciences, Inc. | 42.21M | -4.80% | 2,938,580 | 9.44M |
| 427 | HYPD | Hyperion DeFi, Inc. | 42.11M | 4.63% | 239,450 | 1.40M |
| 428 | OSTX | OS Therapies Incorporated | 40.30M | -2.00% | 327,352 | - |
| 429 | APLM | Apollomics, Inc. | 39.88M | -2.37% | 672 | 413.00K |
| 430 | ALPS | Alps Group Inc | 39.60M | -25.63% | 144,947 | 3.74M |
| 431 | GRDX | GridAI Technologies Corp. | 39.30M | -0.18% | 89,875 | - |
| 432 | ALDX | Aldeyra Therapeutics, Inc. | 39.30M | 3.54% | 1,251,573 | - |
| 433 | GRCE | Grace Therapeutics, Inc. | 39.02M | -0.27% | 8,735 | - |
| 434 | IRLA | IRulya Therapeutics Inc. | 38.98M | -0.75% | 156,418 | - |
| 435 | SER | Serina Therapeutics, Inc. | 38.10M | 4.90% | 17,878 | 130.00K |
| 436 | EXOZ | eXoZymes, Inc. | 37.13M | -0.99% | 9,406 | -700.00 |
| 437 | IBO | Impact BioMedical Inc. | 36.74M | -6.93% | 1,683 | 38.00K |
| 438 | LONA | LeonaBio, Inc. | 36.56M | -3.48% | 32,967 | - |
| 439 | VERU | Veru Inc. | 36.49M | 0.94% | 38,704 | 16.89M |
| 440 | PTHS | Pelthos Therapeutics Inc. | 35.95M | 5.51% | 19,985 | 43.30M |
| 441 | NNVC | NanoViricides, Inc. | 35.22M | -2.82% | 143,788 | - |
| 442 | AARD | Aardvark Therapeutics, Inc. | 34.80M | 16.06% | 387,443 | - |
| 443 | ESLA | Estrella Immunopharma, Inc. | 34.53M | 6.25% | 727,721 | - |
| 444 | INMB | INmune Bio Inc. | 33.83M | - | 282,830 | 50.00K |
| 445 | PMN | ProMIS Neurosciences, Inc. | 33.72M | -5.53% | 110,109 | - |
| 446 | ACET | Adicet Bio, Inc. | 32.19M | -0.33% | 416,462 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 31.10M | -2.71% | 55,970 | - |
| 448 | EYPT | EyePoint, Inc. | 30.74M | -11.75% | 5,835,215 | 2.79M |
| 449 | EDSA | Edesa Biotech, Inc. | 30.00M | 9.90% | 1,001,295 | - |
| 450 | LITS | Lite Strategy, Inc. | 29.95M | 2.86% | 106,378 | - |
| 451 | MGX | Metagenomi Therapeutics, Inc. | 28.57M | 8.04% | 641,560 | 7.09M |
| 452 | NXTC | NextCure, Inc. | 27.37M | - | 93,166 | - |
| 453 | BSEM | BioStem Technologies, Inc. | 27.32M | 41.35% | 1,098,283 | 34.59M |
| 454 | CRVO | CervoMed Inc. | 26.78M | 29.20% | 9,760,426 | 8.73K |
| 455 | PLRZ | Polyrizon Ltd. | 26.76M | 0.80% | 8,077 | - |
| 456 | BYSI | BeyondSpring Inc. | 26.47M | 11.06% | 75,683 | 1.88M |
| 457 | IMMP | Immutep Limited | 25.96M | 2.89% | 58,707 | 13.79M |
| 458 | ABVC | ABVC BioPharma, Inc. | 25.76M | 0.21% | 5,649 | 797.92K |
| 459 | CELU | Celularity Inc. | 24.37M | 5.63% | 66,111 | 18.67M |
| 460 | EVAX | Evaxion A/S | 24.27M | 1.75% | 21,841 | 7.49M |
| 461 | RNAZ | TransCode Therapeutics, Inc. | 23.70M | 3.70% | 11,941 | - |
| 462 | FLNA | Filana Therapeutics, Inc. | 23.29M | -0.04% | 208,141 | - |
| 463 | CVM | CEL-SCI Corporation | 23.04M | -7.09% | 87,889 | - |
| 464 | IGC | IGC Pharma, Inc. | 20.56M | 1.48% | 184,387 | 1.11M |
| 465 | ATOS | Atossa Therapeutics, Inc. | 20.26M | -5.14% | 41,408 | - |
| 466 | CNTX | Context Therapeutics Inc. | 19.86M | 15.56% | 1,244,155 | - |
| 467 | COCP | Cocrystal Pharma, Inc. | 19.65M | -0.97% | 23,638 | 330.00K |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.06M | 0.80% | 4,324 | - |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 17.87M | -4.96% | 444,214 | - |
| 470 | KTTA | Pasithea Therapeutics Corp. | 17.78M | -7.28% | 235,407 | - |
| 471 | AKTX | Akari Therapeutics, Plc | 17.02M | 4.49% | 22,509 | - |
| 472 | BIVI | BioVie Inc. | 16.97M | -0.79% | 137,606 | - |
| 473 | ABOS | Acumen Pharmaceuticals, Inc. | 16.64M | - | 1,158,557 | - |
| 474 | ACTU | Actuate Therapeutics, Inc. | 16.62M | 1.75% | 94,732 | - |
| 475 | ATYR | aTyr Pharma, Inc. | 16.60M | -10.45% | 46,355 | 190.00K |
| 476 | QNTM | Quantum BioPharma Ltd. | 16.43M | -3.96% | 144,540 | - |
| 477 | JSPR | Jasper Therapeutics, Inc. | 16.37M | 0.07% | 69,364 | - |
| 478 | BOLT | Bolt Biotherapeutics, Inc. | 16.19M | -0.63% | 42,533 | 4.70M |
| 479 | NCEL | NewcelX Ltd. | 16.17M | -2.10% | 29,907 | - |
| 480 | MRKR | Marker Therapeutics, Inc. | 15.84M | -0.02% | 28,383 | 3.55M |
| 481 | MCRB | Seres Therapeutics, Inc. | 15.07M | -3.85% | 240,145 | 2.13M |
| 482 | KYNB | Kyntra Bio, Inc. | 14.90M | 3.08% | 19,322 | 4.62M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 14.88M | 2.76% | 97,139 | 345.00K |
| 484 | PLUR | Pluri Inc. | 14.81M | 7.14% | 24,570 | 1.02M |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 14.66M | 0.74% | 34,713 | 1.17M |
| 486 | DYAI | Dyadic International, Inc. | 14.14M | 6.01% | 44,159 | 3.80M |
| 487 | BCDA | BioCardia, Inc. | 13.95M | -0.91% | 58,163 | 3.00K |
| 488 | DARE | Daré Bioscience, Inc. | 13.65M | 0.29% | 71,695 | 1.37M |
| 489 | ALGS | Aligos Therapeutics, Inc. | 13.49M | -15.95% | 282,722 | 33.65M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 13.19M | -2.48% | 176,713 | 7.11M |
| 491 | LPCN | Lipocine Inc. | 13.11M | - | 206,495 | 3.74M |
| 492 | PASG | Passage Bio, Inc. | 12.87M | 5.82% | 27,915 | - |
| 493 | PTN | Palatin Technologies, Inc. | 12.68M | -0.44% | 10,557 | 13.19M |
| 494 | TCRX | TScan Therapeutics, Inc. | 12.58M | 0.22% | 291,792 | 7.11M |
| 495 | PBM | Psyence Biomedical Ltd. | 12.13M | 4.95% | 22,955 | - |
| 496 | GUTS | Fractyl Health, Inc. | 11.69M | 8.70% | 139,741 | 3.00K |
| 497 | PPBT | Purple Biotech Ltd | 11.66M | 11.19% | 20,257 | - |
| 498 | RADX | Radiopharm Theranostics Limited | 11.56M | -2.73% | 7,316 | 8.90M |
| 499 | CLRB | Cellectar Biosciences, Inc. | 11.44M | -0.82% | 17,365 | - |
| 500 | HIND | Vyome Holdings, Inc. | 11.02M | 1.95% | 11,775 | 129.73K |